论文部分内容阅读
目的观察头孢哌酮舒巴坦钠联合盐酸氨溴索治疗新生儿感染性肺炎的临床疗效。方法将我院2011年6月至2012年6月收治的78例感染性肺炎新生儿随机分为对照组与观察组,对照组给予头孢哌酮舒巴坦钠治疗,观察组采取头孢哌酮舒巴坦钠联合盐酸氨溴索治疗,比较两组患者临床治疗效果。结果观察组总有效率为97.44%,明显高于对照组(76.92%),差异有统计学意义(P<0.05)。结论头孢哌酮舒巴坦钠联合盐酸氨溴索治疗新生儿感染性肺炎疗效显著,可明显改善患者临床症状,安全有效,值得推广和应用。
Objective To observe the clinical efficacy of cefoperazone and sulbactam combined with ambroxol hydrochloride in the treatment of neonatal pneumonia. Methods Seventy-eight neonates with infectious pneumonia admitted from June 2011 to June 2012 in our hospital were randomly divided into control group and observation group. The control group was given cefoperazone sulbactam sodium. The observation group was given cefoperazone Batam sodium combined with ambroxol hydrochloride treatment, the clinical efficacy of the two groups were compared. Results The total effective rate in observation group was 97.44%, which was significantly higher than that in control group (76.92%), the difference was statistically significant (P <0.05). Conclusion Cefoperazone sulbactam sodium combined with ambroxol hydrochloride in the treatment of neonatal infectious pneumonia has significant curative effect, which can obviously improve the clinical symptoms of patients and is safe and effective. It is worth to be popularized and applied.